Background: Shigella is a leading cause of bacterial diarrhea morbidity and mortality affecting mainly children under five in the developing world. In Zambia, Shigella has a high prevalence of 34.7% in children with diarrhea and an attributable fraction of 6.7% in Zambian children with moderate to severe diarrhea. Zambian diarrhea management guidelines and the health ministry reporting tool Health Management Information System (HMIS) heavily rely on the WHO clinical classification of dysentery to potentially identify and estimate the burden of Shigella in children. This reliance on clinical dysentery as a proxy to shigellosis in under five children may be resulting in gross under-estimation of shigella disease burden in Zambia.

Methods: We used existing laboratory and clinical data to examine the sensitivity and predictive value of dysentery to correctly identify Shigella infection in under five children with PCR confirmed Shigella infection in Lusaka and Ndola districts, Zambia.

Results: Clinical dysentery had a sensitivity of 8.5% (34/401) in identifying under five children with Shigella by stool PCR. Dysentery was able to correctly classify Shigella in 34 of 68 bloody stool samples giving a corresponding positive predictive value of 50%. Of the 1087 with non-bloody diarrhea, 720 did not have Shigella giving a negative predictive value of 66.2%.

Conclusions: Use of clinical dysentery as a screening symptom for Shigella infection in children under five presenting with moderate to severe diarrhea has low sensitivity and low positive predictive value respectively. Clinical dysentery as a screening symptom for Shigella contributes to gross under diagnosis and reporting of Shigella infection among under five children in Zambia. Further research is required to better inform practice on more accurate methods or tools to use in support of routine diagnosis, particularly in low middle-income settings where laboratory diagnosis remains a challenge.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955635PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0279012PLOS

Publication Analysis

Top Keywords

clinical dysentery
16
shigella infection
16
shigella
12
infection children
12
children
10
sensitivity predictive
8
dysentery
8
predictive dysentery
8
shigellosis children
8
children zambia
8

Similar Publications

Cucurbitacin IIb mitigates concanavalin A-induced acute liver injury by suppressing M1 macrophage polarization.

Int Immunopharmacol

January 2025

Institute of Immunology and Molecular Medicine, Jining Medical University, Jining 272067, China. Electronic address:

Cucurbitacins are a class of triterpenoid compounds extracted from plants and possess various pharmacological applications. Cucurbitacin IIb (CuIIb), extracted from the medicinal plant Hemsleya amabilis (Cucurbitaceae), has served as a traditional Chinese medicine for the treatment of bacterial dysentery and intestinal inflammation. CuIIb has been shown to exhibit anti-inflammatory activity; however, the protective effect of CuIIb against concanavalin A (Con A)-induced acute liver injury (ALI) and the fundamental mechanism remain unelucidated.

View Article and Find Full Text PDF

With increasing antibiotic resistance in gram-negative bacteria, including those causing Shigellosis, evidence of safety and pharmacokinetics data on new oral antibiotics is crucial. We aimed to investigate the safety and pharmacokinetic properties of an oral carbapenem, tebipenem pivoxil, along with it's ability to produce desired results in childhood shigellosis. This randomized pilot clinical trial was conducted at Dhaka Hospital, icddr,b in 2022 between May and September.

View Article and Find Full Text PDF

Background: Ulcerative colitis (UC) is a chronic non-specific inflammatory intestinal disease, categoried under "dysentery" and "intestinal bleeding" in Traditional Chinese Medicine (TCM). Jianpi Qingchang decoction (JPQC) is a combination formula specifically designed for the treatment of UC. The primary objective of this study is to examine the clinical efficacy of JPQC in individuals diagnosed with UC who exhibit both spleen deficiency and dampness-heat syndrome, along with the presence of fatigue.

View Article and Find Full Text PDF

Oral bacteriophage therapy effectively prevent and control of Clostridium perfringens type c infections in newborn piglets.

Vet Microbiol

January 2025

College of Animal Science and Technology, Guangxi University, PR China; Guangxi Key Laboratory of Animal Reproduction, Breeding and Disease Control,  PR China; Guangxi Zhuang Autonomous Region Engineering Research Center of Veterinary Biologics, Nanning 530004, PR China. Electronic address:

Clostridium perfringens (C. perfringens) type C exhibits strong pathogenicity, often leading to swine dysentery, severely affecting the economic efficiency of the pig farming industry. Bacteriophages as bacterial viruses have many natural advantages and are potent candidates for controlling bacterial infections.

View Article and Find Full Text PDF
Article Synopsis
  • Entamoeba histolytica is a parasite causing intestinal amebiasis, particularly prevalent in tropical areas and a major health issue in developing countries. Traditional diagnostic methods can cause delays in treatment, exacerbating patient conditions.
  • A case involving a 59-year-old HIV-positive man revealed how initial testing misdiagnosed his illness, but advanced diagnostics using the FilmArray GI Panel quickly identified E. histolytica in under an hour.
  • The successful and prompt treatment with antiamoebic drugs significantly improved the patient's health, highlighting the importance of rapid diagnosis in managing gastrointestinal infections effectively.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!